Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
July 31, 2000
Study Completion Date
August 31, 2007
Conditions
Esophageal Cancer
Interventions
DRUG
alvocidib
DRUG
paclitaxel
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00006245 - Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | Biotech Hunter | Biotech Hunter